Aspen Pharmacare CEO Stephen Saad. Picture: FINANCIAL MAIL
Aspen Pharmacare CEO Stephen Saad. Picture: FINANCIAL MAIL

Aspen has agreed to sell its Japanese business to a division of Novartis in a bid to reduce its debt levels.

The company’s debt has been whittled down to nearly R40bn from more than R53bn.

CEO Stephen Saad joined Business Day TV to discuss how the deal and its effect on reducing debt levels.

Or listen to the full audio: